DarioHealth Corp.
DRIO
$9.14
-$0.06-0.65%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.37M | 6.75M | 7.60M | 7.42M | 6.26M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.37M | 6.75M | 7.60M | 7.42M | 6.26M |
| Cost of Revenue | 1.97M | 2.00M | 2.11M | 2.20M | 2.27M |
| Gross Profit | 3.40M | 4.76M | 5.49M | 5.22M | 3.99M |
| SG&A Expenses | 8.44M | 9.18M | 9.86M | 10.46M | 12.14M |
| Depreciation & Amortization | 433.00K | 875.00K | 1.29M | 1.34M | 1.23M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.57M | 16.16M | 18.54M | 19.45M | 22.45M |
| Operating Income | -9.20M | -9.41M | -10.94M | -12.03M | -16.19M |
| Income Before Tax | -12.99M | -9.21M | -9.48M | -12.34M | -13.61M |
| Income Tax Expenses | -- | 22.00K | 155.00K | -13.00K | -- |
| Earnings from Continuing Operations | -12.99M | -9.23M | -9.63M | -12.33M | -13.61M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.99M | -9.23M | -9.63M | -12.33M | -13.61M |
| EBIT | -9.20M | -9.41M | -10.94M | -12.03M | -16.19M |
| EBITDA | -8.40M | -8.15M | -8.38M | -10.32M | -14.35M |
| EPS Basic | -3.54 | -2.87 | -2.48 | -4.91 | -1.69 |
| Normalized Basic EPS | -3.27 | -2.43 | -1.39 | -3.82 | -4.27 |
| EPS Diluted | -3.54 | -2.87 | -2.48 | -5.00 | -1.69 |
| Normalized Diluted EPS | -3.27 | -2.43 | -1.39 | -3.82 | -4.27 |
| Average Basic Shares Outstanding | 2.48M | 2.37M | 3.94M | 2.02M | 1.99M |
| Average Diluted Shares Outstanding | 2.48M | 2.37M | 3.94M | 2.02M | 1.99M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |